drugset
drugset / Trial / NCT07353307

A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China.

NCT07353307 ↗

Phase 3 Completed 333 enrolled The Third Xiangya Hospital of Central South University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A multicenter, randomized, double-blind, placebo-positive, parallel-controlled, phase Ⅲ clinical trial of the efficacy, safety and pharmacokinetics of TRD303 solution for postoperative analgesia in patients undergoing abdominal surgery was conducted. The primary objective was to evaluate the efficacy of TRD303 solution for postoperative analgesia after abdominal surgery. The secondary objective was to evaluate the safety and pharmacokinetic profile of TRD303 solution for postoperative analgesia after abdominal surgery.

Timeline

Start
2025-12-30
Primary completion
2026-04-21
Completion
2026-06-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.5 % Other
Comparator Ropivacaine Other / unclassified 30 ml Other
Subject TRD303 Unknown 2.5 ml Other

Indications

No indication recorded.